You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百濟神州(06160.HK)收購美國新澤西州用地作生產基地及臨床研發中心
阿思達克 11-24 09:01
百濟神州(06160.HK)公布,已完成在美國新澤西州霍普韋爾的普林斯頓西部創新園區的用地收購,用於建設一個佔地42英畝、即約17萬平方米的生產基地及臨床研發中心。公司表示,於美國投資建設生產基地可進一步擴大及豐富其全球供應鏈,為公司生物藥產品管線及候選藥物建設新的產能。 公司指,待開發計劃最終確認後,除購買土地外,預計還將投資數億美元用於園區的初步建設。該生產基地及臨床研發中心將建成最高可達40萬平方英尺、即約3.7萬平方米的商業化階段的生物藥生產,其中包括最多16,000升生物製劑產能。該基地並將為臨床研發及辦公提供場所。初期建設將於2022年啟動,並在2023年底或2024年竣工。基地並預留超過100萬平方英尺、即約9.29萬平方米的可開發地產,以備進一步拓展。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account